Welcome to our dedicated page for Ncs Multistage Hldgs SEC filings (Ticker: NCSM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The NCS Multistage Holdings, Inc. (NASDAQ: NCSM) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. NCS Multistage operates in support activities for oil and gas operations, supplying highly engineered products and support services for oil and natural gas well construction, well completions and field development strategies. Its filings offer detail on how this business is performing and evolving over time.
Among the key documents are current reports on Form 8-K, which NCS Multistage uses to announce material events such as quarterly financial results. For example, the company has filed 8-K reports to furnish press releases covering results for quarters ended June 30, 2025 and September 30, 2025. These filings typically include information on revenues, net income, adjusted EBITDA and commentary on regional activity in markets such as the United States, Canada and selected international regions.
In addition to 8-Ks, investors commonly review annual reports on Form 10-K and quarterly reports on Form 10-Q, where available, to understand segment performance, risk factors, and details related to products and services like tracer diagnostics and reservoir analysis. Proxy statements can provide information on governance and executive compensation, while registration statements and other filings may address capital structure and financing activities.
On Stock Titan, these SEC filings are paired with AI-powered summaries that highlight the main points of lengthy documents, helping users interpret complex disclosures. Real-time updates from the SEC’s EDGAR system ensure that new NCS Multistage filings, including Forms 10-K, 10-Q and 8-K, appear promptly. Users can also review insider transaction reports on Form 4 when available, gaining additional insight into trading activity by NCS Multistage officers and directors.
NCS Multistage Holdings, Inc. reported significantly stronger results for the quarter and year ended December 31, 2025. Full-year revenue reached $183.6 million, up 13% from 2024, driven by higher product sales in all regions and stronger services in the United States and Canada.
Full-year net income rose to $23.7 million, or $8.65 per diluted share, helped by a $9.2 million income tax benefit from reversing most deferred tax valuation allowances. Adjusted EBITDA increased to $26.7 million with a 15% margin, while free cash flow after distributions to non-controlling interest nearly doubled to $18.9 million.
The company ended 2025 with $36.7 million in cash and $7.6 million of finance-lease-related debt, reflecting a net cash position and expanded financial flexibility. Management highlighted the contribution from the ResMetrics acquisition and expects a challenging 2026 activity environment but aims to outperform markets through share gains and international growth.
NCS Multistage Holdings VP & Controller Dewayne Williams reported several equity-related transactions. On March 3, 2026, he received 1,366 equivalent stock units and 1,366 shares of common stock as grants at no cost. On February 28, 2026, he exercised 4,535 equivalent stock units into the same number of common shares and then surrendered 4,535 shares to cover tax obligations and disposed of an additional 301 shares to the issuer at $39.84 per share. Footnotes state the equivalent stock units are cash-settled instruments economically equal to one share, with payouts capped by the Compensation, Nominating and Governance Committee, and that his remaining holdings include restricted stock units and equivalent stock units vesting in installments beginning on February 28, 2027.
NCS Multistage Holdings Executive VP, GC and Secretary Lev Ori reported a mix of equity awards, conversions, and related share dispositions. On February 28, 2026, 5,289 equivalent stock units vested and were exercised into the same number of common shares. A portion of these shares, including 5,289 shares at $39.84 per share and an additional 374 shares, was surrendered to the company to cover tax obligations and issuer-related dispositions tied to vesting.
On March 2, 2026, Ori received a grant of 6,853 common shares and disposed of 1,730 shares to the issuer at $40.93 per share. On March 3, 2026, he was granted 1,940 equivalent stock units settling in cash, 3,921 performance stock units linked to relative total shareholder return that may settle for between zero and 1.25 shares each in the first quarter of 2029, and 1,940 common shares. Following these transactions, Ori directly held 14,387 common shares and 3,921 performance stock units, alongside additional unvested equivalent and restricted stock units.
NCS Multistage Holdings CFO & Treasurer Michael L. Morrison reported a mix of equity awards, vesting events, and related share dispositions. On February 28, 2026, 4,972 equivalent stock units vested and were settled in cash, and 4,972 shares of common stock were issued, with 4,972 shares and an additional 262 shares of common stock surrendered to cover tax obligations and dispositions to the issuer at prices of $39.84 per share.
On March 2, 2026, he acquired 7,996 shares of common stock at a stated price of $0.00 per share, with 2,019 shares disposed to the issuer at $40.93 per share. On March 3, 2026, he received 2,463 equivalent stock units and 2,463 shares of common stock tied to restricted stock units, as well as 4,978 performance stock units that can settle for between zero and 1.25 shares of common stock per unit in the first quarter of 2029 based on relative total shareholder return performance.
NCS Multistage Holdings Chief Operations Officer Tim Willems reported a mix of equity grants, conversions and share surrenders. On March 3, he received 2,498 equivalent stock units that settle in cash, 5,047 performance stock units tied to relative total shareholder return, and 2,498 shares of common stock as awards.
On March 2, he was granted 9,173 additional common shares and disposed of 2,316 shares back to the issuer. On February 28, 6,880 equivalent stock units vested and converted into 6,880 common shares, with 6,880 shares and another 489 shares surrendered at prices of $39.84 and $40.93 to satisfy tax and issuer-related obligations.
NCS Multistage Holdings, Inc. director and Chief Executive Officer Ryan Hummer reported a mix of equity awards, conversions and share dispositions. On February 28, 2026, 10,211 equivalent stock units vested and were exercised into common stock, with related common shares partly surrendered to the issuer and partly used to cover tax obligations at prices noted in the filing.
On March 2–3, 2026, Hummer received additional grants of common stock, equivalent stock units and performance stock units at no cash cost, increasing his directly held common stock and derivative awards. The performance stock units can ultimately settle for between zero and 1.25 shares of common stock per unit in the first quarter of 2029, based on relative total shareholder return and an absolute return modifier.
MCSHANE MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
NCS Multistage Holdings, Inc. director Michael McShane reported receiving an equity award of 3,221 shares of common stock in the form of restricted stock units at a price of $0.00 per share. These 3,221 restricted stock units are scheduled to vest and settle on February 28, 2027.
After this grant, McShane’s directly held common stock, including the new restricted stock units, totals 48,778 shares. This is a non-cash, stock-based compensation award rather than an open-market purchase.
NCS Multistage Holdings director John D. Deane received an award of 3,221 shares of common stock on March 3, 2026 through a grant or similar acquisition at no stated price. Following this award, his directly held common stock totaled 32,771 shares, including 3,221 restricted stock units that vest and settle on February 28, 2027.
The filing also reports 10,731 shares of common stock held indirectly by the Deane Family Partnership Limited, a limited partnership for which Deane is the sole general partner. He disclaims beneficial ownership of these indirectly held securities except to the extent of his pecuniary interest in them.
NCS Multistage Holdings director Robert Nipper reported an equity award and updated his holdings. He acquired 3,221 shares of common stock at a price of
Mitchell Valerie A reported acquisition or exercise transactions in this Form 4 filing.
NCS Multistage Holdings director Valerie A. Mitchell received an equity award of 3,221 shares of common stock in the form of restricted stock units. These units were granted at no cash cost and increase her direct holdings to 26,772 shares. The 3,221 restricted stock units vest and settle on February 28, 2027, while 19,212 previously vested restricted stock units are scheduled to settle within thirty days after her service ends or a change of control, whichever occurs first.